Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▴	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
ALMS	Alumis Inc. Manufacturing · Year ended 2025-12-31 · USD	$24.05M	-$243.32M	n/m	-80.8%	n/a	-$2.86
ALNY	Alnylam Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.71B	$313.75M	8.4%	39.8%	65.2%	$2.33
ALT	Altimmune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$41.0K	-$88.09M	n/m	-39.2%	105.0%	-$1.00
ALXO	ALX Oncology Holdings Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$101.69M	n/a	-391.4%	n/a	-$1.90
ALZN	Alzamend Neuro, Inc. Manufacturing · Year ended 2026-04-30 · USD	n/a	-$8.77M	n/a	n/m	n/a	-$2.63
AMLX	Amylyx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$144.74M	n/a	-47.4%	-100.0%	-$1.53
AMPH	Amphastar Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$719.89M	$98.09M	13.6%	12.4%	-1.7%	$2.03
AMRN	Amarin Corp PLC Manufacturing · Year ended 2025-12-31 · USD	$213.65M	-$38.80M	-18.2%	-8.4%	-6.5%	-$0.09
AMRX	Amneal Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.02B	$72.06M	2.4%	n/a	8.0%	$0.22
ANAB	Anaptysbio, Inc Manufacturing · Year ended 2025-12-31 · USD	$234.60M	-$13.23M	-5.6%	-35.6%	157.0%	-$0.46
ANEB	Anebulo Pharmaceuticals, Inc. Manufacturing · Year ended 2025-06-30 · USD	n/a	-$8.48M	n/a	-72.8%	n/a	-$0.25
ANIP	ANI Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$883.37M	$78.34M	8.9%	14.5%	43.8%	$3.32
ANIX	Anixa Biosciences Inc Manufacturing · Year ended 2025-10-31 · USD	n/a	-$10.93M	n/a	-72.1%	n/a	-$0.34
ANNX	Annexon, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$206.69M	n/a	-97.7%	n/a	-$1.34
ANRO	Alto Neuroscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$63.24M	n/a	-41.8%	n/a	-$2.19
ANTX	AN2 Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$35.17M	n/a	-66.3%	n/a	-$1.16
ANVS	Annovis Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$28.85M	n/a	-171.2%	n/a	-$1.40
APRE	Aprea Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.60M	n/a	-101.3%	n/a	-$1.93
APUS	Apimeds Pharmaceuticals US, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$6.00M	n/a	-3.9%	n/a	-$0.55
APVO	Aptevo Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$25.97M	n/a	-149.4%	n/a	-$87.27
AQST	Aquestive Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$44.55M	-$83.78M	-188.1%	n/a	-22.6%	-$0.78
ARCT	Arcturus Therapeutics Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$82.03M	-$65.78M	-80.2%	-30.7%	-46.1%	-$2.40
ARDX	Ardelyx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$407.32M	-$61.60M	-15.1%	-36.9%	22.1%	-$0.26
ARQT	Arcutis Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$372.07M	-$16.14M	-4.3%	-8.5%	123.4%	-$0.13
ARTL	Artelo Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.88M	n/a	n/a	n/a	-$12.52

Rows per page: 2550 100